
Jeremy M. Levin
Executive Chairman · Ovid Therapeutics Inc.
- 2026
- Mar 26, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeremy M. Levin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Margaret A. Alexander - $17K in OVID purchases and sales in the last 12 months
- Jeffrey A. Rona - $12K in OVID purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeremy M. Levin?
Jeremy M. Levin is a corporate insider, tracked as Executive Chairman of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jeremy M. Levin last file a Form 4?
The most recent primary Form 4 on record is dated 26 March 2026, one of 2 filings going back to 2026.